The PEOPLE study, a prospective phase II trial (N = 65), discovered a correlation between E. massiliensis and PFS in patients with advanced NSCLC who had PD-L1 levels below 50% [113]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.